Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eric W Holroyd"'
Autor:
Chun Shing Kwok, Eric W Holroyd, Aditya Narain, Ted S. Lo, Mamas A. Mamas, M. Chadi Alraies, James Nolan, Homam Moussa Pacha
Publikováno v:
Cardiovascular Revascularization Medicine. 21:375-391
Background Readmissions after PCI are a burden to patients and health services that are not well understood. Methods A systematic review was performed to identify studies of readmission after PCI. Readmission rates and causes of readmission were exam
Autor:
Robert Butler, Ashish Patwala, Saul Lovatt, Yoon K. Loke, Chun Shing Kwok, Christian D Mallen, Chun Wai Wong, Eric W Holroyd, Thanh Phan
Publikováno v:
International Journal of Clinical Practice. 75
Background: Smoking cessation is an effective secondary prevention measure after acute coronary syndrome (ACS). We conducted a systematic review with the aim to better understand which patients have a greater propensity to quit smoking and the risk f
Publikováno v:
Interventional Cardiology. 7:305-315
Percutaneous coronary intervention (PCI) is the commonest form of revascularization in patients with coronary heart disease. The benefit of early invasive treatment with PCI in patients presenting with acute coronary syndromes are well accepted. Trad
Autor:
Benjamin Wrigley, James Cotton, Eric W Holroyd, V Amoah, Angel L. Armesilla, Alan M. Nevill, Andrew Smallwood
Publikováno v:
SAGE Open Medicine, Vol 4 (2016)
SAGE Open Medicine
SAGE Open Medicine
Introduction:We evaluated the association between two single nucleotide polymorphisms of the vascular endothelial growth factor gene and one of the hypoxia-inducible factor-1α gene and the degree of coronary collateral formation in patients with a c
Autor:
Laurel S. Kleppe, Cheryl S. Mueske, Debabrata Mukhopadhyay, Ling Wang, Tyra A. Witt, Sinny Delacroix, Robert D. Simari, Eric W. Holroyd, Peter J. Psaltis, Katarina Larsen, Shuchong Pan, Adriana Harbuzariu, Thomas A. White
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 32:704-711
Objective— Tissue factor pathway inhibitor (TFPI) is the primary regulator of the tissue factor (TF) coagulation pathway. As such, TFPI may regulate the proangiogenic effects of TF. TFPI may also affect angiogenesis independently of TF, through seq
Publikováno v:
Frontiers in Bioscience. :392-400
Tissue factor pathway inhibitor (TFPI) is a potent regulator of tissue factor – factor VII-dependent activation of the tissue factor pathway. TFPI is a serine protease inhibitor that contains three Kunitz domains and a basic carboxyl terminus. TFPI
Publikováno v:
Journal of Cardiovascular Translational Research. 4:161-176
The fundamental contributions that blood vessels make toward organogenesis and tissue homeostasis are reflected by the considerable ramifications that loss of vascular wall integrity has on pre- and postnatal health. During both neovascularization an
Autor:
David Hildick-Smith, A D Simms, Eric W. Holroyd, Daniel J. Blackman, Petra Poliacikova, Richard D. Levy, Ganesh Manoharan, Saib Khogali, Mark S. Spence
Publikováno v:
Journal of the American College of Cardiology. 62(18)
Permanent pacemaker (PPM) requirement is a recognised complication of Transcatheter Aortic Valve implantation (TAVI) (published rate of 16-40%) and surgical aortic valve replacement(AVR)(8% of cases). PPM requirement post CoreValve TAVI is influenced
Autor:
Peter J. Psaltis, Robert D. Simari, Adriana Harbuzariu, Tyra A. Witt, Eric W. Holroyd, Scott J. Hoffman, Sinny Delacroix, Shuchong Pan, Laurel S. Kleppe, Rajiv Gulati, Gurpreet S. Sandhu, Daniel B. Spoon, Cheryl S. Mueske
Publikováno v:
Circulation. 125(4)
Background— Hematopoiesis originates from the dorsal aorta during embryogenesis. Although adult blood vessels harbor progenitor populations for endothelial and smooth muscle cells, it is not known if they contain hematopoietic progenitor or stem ce
Autor:
Sinny Delacroix, Natalia Zarzhevsky, Shuchong Pan, Ripudamanjit Singh, Cindy W. Tom, Susan A. Maroney, Alan E. Mast, Gurpreet S. Sandhu, Thomas A. White, Jan M. van Deursen, Robert D. Simari, Eric W. Holroyd, William P. Fay, Tucker F. Johnson
Publikováno v:
Blood, 116, 1787-94
Blood, 116, 10, pp. 1787-94
Blood, 116, 10, pp. 1787-94
The antithrombotic surface of endothelium is regulated in a coordinated manner. Tissue factor pathway inhibitor (TFPI) localized at the endothelial cell surface regulates the production of FXa by inhibiting the TF/VIIa complex. Systemic homozygotic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20553c8c1ef4319ccd313dde1541c404
http://hdl.handle.net/2066/88679
http://hdl.handle.net/2066/88679